Iovance Biotherapeutics, Inc. (IOVA)

NASDAQ: IOVA · Real-Time Price · USD

5.41

+0.28 (5.46%)

At close: Mar 9, 2026, 4:00 PM EDT

5.40

-0.01 (-0.18%)

After-hours: Mar 9, 2026, 6:54 PM EDT

Iovance Biotherapeutics Employees

Iovance Biotherapeutics had 975 employees as of December 31, 2025. The number of employees increased by 137 or 16.35% compared to the previous year.

Employees

975

Change (1Y)

137

Growth (1Y)

16.35%

Revenue / Employee

$270,258

Profits / Employee

-$401,003

Market Cap

2.23B

Employees Chart

Date	Employees	Change	Growth
Dec 31, 2025	975	137	16.35%
Dec 31, 2024	838	281	50.45%
Dec 31, 2023	557	54	10.74%
Dec 31, 2022	503	184	57.68%
Dec 31, 2021	319	78	32.37%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Company Name	Employees
Zai Lab	1,869
Ultragenyx Pharmaceutical	1,371
Ascentage Pharma Group International	605
Galapagos NV	558
Ocular Therapeutix	325
Soleno Therapeutics	182
Day One Biopharmaceuticals	178
Stoke Therapeutics	128